HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$4.88
Day range
$4.95 - $5.11
Year range
$2.96 - $11.45
Market cap
55.05M USD
Avg Volume
25.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.34M | -3.96% |
Net income | -18.84M | -76.75% |
Net profit margin | — | — |
Earnings per share | -1.39 | -9.45% |
EBITDA | -10.27M | 3.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.02M | 84.31% |
Total assets | 38.39M | 23.88% |
Total liabilities | 57.37M | 224.13% |
Total equity | -18.99M | — |
Shares outstanding | 10.78M | — |
Price to book | -2.77 | — |
Return on assets | -95.53% | — |
Return on capital | -437.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -18.84M | -76.75% |
Cash from operations | -7.27M | -40.29% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 30.75M | 51,156.67% |
Net change in cash | 23.52M | 555.03% |
Free cash flow | -5.90M | -130.09% |
About
Founded
2011
Headquarters
Website
Employees
32
